Literature DB >> 4147190

The effect of -adrenoceptor blockade on human sweating.

J A Allen, D J Jenkinson, I C Roddie.   

Abstract

1. Changes in cutaneous water loss were followed by continuously monitoring total body weight loss.2. Sweating was induced in normal subjects by raising the environmental temperature or by subjecting them to the emotional stress of mental arithmetic.3. Propranolol in a dosage of 0.15 mg/kg body weight intravenously had no significant effect on either thermal or emotional sweating, whereas thermal sweating was completely blocked temporarily by administration of atropine 2.4 mg intravenously.4. It is concluded that beta-adrenoceptor blockade has no effect on physiological sweating in normal people.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4147190      PMCID: PMC1776319          DOI: 10.1111/j.1476-5381.1973.tb08180.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  Chronotropic and vagal-blocking effects of DCI studied by direct perfusion of the sinus node.

Authors:  T N JAMES; R A NADEAU
Journal:  J Pharmacol Exp Ther       Date:  1963-04       Impact factor: 4.030

2.  Insensible weight loss at high skin temperatures.

Authors:  P WEBB; L N GARLINGTON; M J SCHWARZ
Journal:  J Appl Physiol       Date:  1957-07       Impact factor: 3.531

3.  The nervous and chemical control of sweating.

Authors:  T M CHALMERS; C A KEELE
Journal:  Br J Dermatol       Date:  1952-02       Impact factor: 9.302

4.  Effect of five beta-adrenoceptor antagonists on the effect of isoprenaline and acetylcholine on human isolated smooth muscle.

Authors:  A Hedges; P Turner
Journal:  Br J Pharmacol       Date:  1971-02       Impact factor: 8.739

5.  Beta adrenergic blocking properties of D and DL propränolol in man.

Authors:  I Brick; K J Hutchinson; I C Roddie
Journal:  Ir J Med Sci       Date:  1970-03       Impact factor: 1.568

6.  Controlled trial of propranolol in thyrotoxicosis.

Authors:  R G Shanks; D R Hadden; D C Lowe; D G McDevitt; D A Montgomery
Journal:  Lancet       Date:  1969-05-17       Impact factor: 79.321

7.  A body balance to measure sweat rates in man.

Authors:  J A Allen; J F Grimley; I C Roddie
Journal:  Biomed Eng       Date:  1971-10

8.  Effects of cholinergic and adrenergic blocking agents on the activity of the eccrine sweat glands.

Authors:  K G Foster; J S Weiner
Journal:  J Physiol       Date:  1970-11       Impact factor: 5.182

9.  Influence of the rate of sweating on the inhibitory dose of atropine.

Authors:  E G Cummings; F N Craig
Journal:  J Appl Physiol       Date:  1967-04       Impact factor: 3.531

10.  The role of circulating catecholamines in sweat production in man.

Authors:  J A Allen; I C Roddie
Journal:  J Physiol       Date:  1972-12       Impact factor: 5.182

View more
  6 in total

1.  β-Adrenergic receptor blockade does not modify non-thermal sweating during static exercise and following muscle ischemia in habitually trained individuals.

Authors:  Tatsuro Amano; Anna Igarashi; Naoto Fujii; Daichi Hiramatsu; Yoshimitsu Inoue; Narihiko Kondo
Journal:  Eur J Appl Physiol       Date:  2018-09-20       Impact factor: 3.078

2.  Human responses to emotional stress.

Authors:  I C Roddie
Journal:  Ir J Med Sci       Date:  1977-12       Impact factor: 1.568

3.  The regional distribution of emotional sweating in man.

Authors:  J A Allen; J E Armstrong; I C Roddie
Journal:  J Physiol       Date:  1973-12       Impact factor: 5.182

4.  The effect of antidiuretic hormone on human sweating.

Authors:  J A Allen; I C Roddie
Journal:  J Physiol       Date:  1974-01       Impact factor: 5.182

5.  The effect of β-adrenoceptor blockade on body temperature and plasma renin activity in heat-exposed man.

Authors:  G M Berlyne; J P Finberg; C Yoran
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

6.  The effect of pain on human sweating.

Authors:  W P Abram; J A Allen; I C Roddie
Journal:  J Physiol       Date:  1973-12       Impact factor: 5.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.